Single fraction multimodal image guided focal salvage high-dose-rate brachytherapy for recurrent prostate cancer. - sprookjes - yvandenbroek - TriplyDB

Single fraction multimodal image guided focal salvage high-dose-rate brachytherapy for recurrent prostate cancer.

Single fraction multimodal image guided focal salvage high-dose-rate brachytherapy for recurrent prostate cancer.

http://www.wikidata.org/entity/Q30376901

about

Clinical use of magnetic resonance imaging across the prostate brachytherapy workflow.Comparison of PET/CT and whole-mount histopathology sections of the human prostate: a new strategy for voxel-wise evaluation.Focal therapy for prostate cancer: the technical challenges.Second salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer.Focal MRI-Guided Salvage High-Dose-Rate Brachytherapy in Patients With Radiorecurrent Prostate Cancer.The dose distribution in dominant intraprostatic tumour lesions defined by multiparametric MRI and PSMA PET/CT correlates with the outcome in patients treated with primary radiation therapy for prostate cancer.Focal dose escalation for prostate cancer using 68Ga-HBED-CC PSMA PET/CT and MRI: a planning study based on histology reference.

P2860

Q39116395-A9D4A2ED-FF1C-4F64-B94E-57172554B6A7 Q41436127-3012B64D-04DC-4668-BA56-06718DEA6E09 Q41689116-8105A55E-D29D-4096-951F-F2CD8896C727 Q42257056-41332244-80EA-4013-B361-62D4E1859CA6 Q49765143-56998150-6285-46C8-BD1B-E9F6E74C548C Q55077981-3CCF5CDC-CB5C-4A02-911F-BDB2D686E5FA Q55317289-E8CB298F-CBE5-4547-9153-84D4A1862DF9

P2860

Single fraction multimodal image guided focal salvage high-dose-rate brachytherapy for recurrent prostate cancer.

http://www.wikidata.org/entity/Q30376901

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Single fraction multimodal ima ...... for recurrent prostate cancer.

@ast

Single fraction multimodal ima ...... for recurrent prostate cancer.

@en

type

label

Single fraction multimodal ima ...... for recurrent prostate cancer.

@ast

Single fraction multimodal ima ...... for recurrent prostate cancer.

@en

prefLabel

Single fraction multimodal ima ...... for recurrent prostate cancer.

@ast

Single fraction multimodal ima ...... for recurrent prostate cancer.

@en

P1433

Q30376901-5A90924D-F1AE-4736-B255-A0F26B15D87D

P1476

Q30376901-BB596308-3505-4DF6-B88F-58482D513B99

P2093

Q30376901-3D1186F7-3C53-4926-8F76-D30ADE70DA33

Q30376901-4535BC8B-8AB1-49B9-95E3-A6121C0466D7

Q30376901-52D2258E-FF13-4612-A0D8-8AD4AB482DAA

Q30376901-7E6447A9-DCD0-4B61-800C-BB8313745D3E

Q30376901-83F2BC57-78A0-44EE-B2F0-0DF0B8C809BE

Q30376901-A816BFCF-39BF-460E-B397-D935D5FE658E

Q30376901-AB009F25-A405-4AC1-8EC5-F1CCD1AB9E4B

Q30376901-CFC29183-766A-46CB-B65B-FD05795440E8

Q30376901-E62F2003-3190-4A5B-8D63-861C939AC506

Q30376901-E64C68FF-A492-40F4-9962-27D77D8F1CC2

P2860

Q30376901-16DAA2B5-19E2-40D6-B9B9-0E50B8C8FA72

Q30376901-1B274D26-BF20-4919-AD7A-E0148DEECB07

Q30376901-2096FADE-2934-4622-8A1E-406A2E42D404

Q30376901-2905D265-D01D-4C8E-BBEA-92C1F12B5065

Q30376901-29BB48F1-834B-4A77-8699-D8D90993336F

Q30376901-2EB8AA45-DFF3-4AA6-85DB-EB44A7F3A35A

Q30376901-3A91627F-72F2-4FD2-9E36-F7514B99CB45

Q30376901-40C84882-9313-4973-9832-6D2FF0E931E5

Q30376901-4244E4EA-2333-46E6-B09C-EAE8798D8F41

Q30376901-563637DE-AC58-4B2B-B293-97E316D46C6A

P304

Q30376901-62E28FFE-23FA-4C87-9A02-CB40ACEA1FEB

P31

Q30376901-0a8cb1a9-05f7-4abc-929c-43028c026cd0

Q30376901-D59C41DC-5D32-4D05-9169-3445B76EF7E9

P356

Q30376901-12C2C48F-5FB4-4EA9-91CA-88C347F2B6D8

P433

Q30376901-F753BFD6-FC46-428B-A60D-696DAFE4F815

P478

Q30376901-FA5B0CB0-175F-488D-BFAC-D25ACAA8C88B

P577

Q30376901-FFBA76AB-04C1-46A3-A1EB-B23968F311B1

P698

Q30376901-CA368FE2-590F-4029-8088-49A264928105

P921

Q30376901-A024674D-FF46-4B63-B8AB-3D7663371718

P932

Q30376901-2B96B4D8-6521-46E4-B290-5EB658D2D35D

P356

P1433

Journal of contemporary brachytherapy

P1476

Single fraction multimodal ima ...... for recurrent prostate cancer.

@en

P2093

Anca Ligia Grosu

http://www.w3.org/2001/XMLSchema#string

Constantinos Zamboglou

http://www.w3.org/2001/XMLSchema#string

Cordula Annette Jilg

http://www.w3.org/2001/XMLSchema#string

Dimos Baltas

http://www.w3.org/2001/XMLSchema#string

Hans-Christian Rischke

http://www.w3.org/2001/XMLSchema#string

Malte Kroenig

http://www.w3.org/2001/XMLSchema#string

Michael Kollefrath

http://www.w3.org/2001/XMLSchema#string

Natalja Volgeova-Neher

http://www.w3.org/2001/XMLSchema#string

Philipp Tobias Meyer

http://www.w3.org/2001/XMLSchema#string

Sven Knobe

http://www.w3.org/2001/XMLSchema#string

P2860

High-intensity focused ultrasound for prostate cancer: a systematic review.

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.

Salvage cryotherapy for radiation-recurrent prostate cancer: outcomes and complications.

Brachytherapy for recurrent prostate cancer after radiation therapy.

Long-term results of interstitial brachytherapy (LDR-Brachytherapy) in the treatment of patients with prostate cancer.

Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature.

Salvage surgery for locally recurrent prostate cancer after radiation therapy: tricks of the trade.

Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer.

AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137.

Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I(125) prostate brachytherapy in clinically localized prostate cancer: Seattle experience.

P304

241-248

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/JCB.2016.61067

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27504134

http://www.w3.org/2001/XMLSchema#string

P921

P932

4965505

http://www.w3.org/2001/XMLSchema#string